Related Experiment Video
Updated: Dec 10, 2025

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
Activity of airway antimicrobial peptides against cystic fibrosis pathogens
Andrea Cabak1, Gisela Hovold1, Ann-Cathrine Petersson2
1Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, BMC B14, Sölvegatan 19, S-221 84 Lund, Sweden.
Abstract:
Antimicrobial peptides are important players of the innate host defence against invading microorganisms. The aim of this study was to evaluate the activity of airway antimicrobial peptides against the common cystic fibrosis (CF) pathogen Pseudomonas aeruginosa, and to compare it to the emerging multi-drug resistant CF pathogens Achromobacter xylosoxidans and Stenotrophomonas maltophilia. Clinical bacterial isolates from CF patients were used, and the antimicrobial activity of human beta-defensin 2 and 3, LL37 and lysozyme was evaluated using radial diffusion assay and viable counts. The cell surface zeta potential was analysed to estimate the net charge at the bacterial surface. Of the bacterial species included in the study, A. xylosoxidans was the most resistant to antimicrobial peptides, whereas P. aeruginosa was the most susceptible. The net charge of the bacterial surface was significantly more negative for P. aeruginosa compared to A. xylosoxidans, which may in part explain the differences in susceptibility.
Insights
Airway antimicrobial peptides show varying activity against cystic fibrosis pathogens. Achromobacter xylosoxidans is more resistant than Pseudomonas aeruginosa, potentially due to differences in bacterial surface charge.
Area of Science:
- Innate immunity
- Microbiology
- Host-pathogen interactions
Background:
- Antimicrobial peptides (AMPs) are crucial for innate host defense against microbes.
- Cystic Fibrosis (CF) patients are susceptible to infections by pathogens like Pseudomonas aeruginosa, Achromobacter xylosoxidans, and Stenotrophomonas maltophilia.
- Understanding AMP activity against these CF pathogens is vital for developing new treatments.
Purpose of the Study:
- To assess the activity of key airway antimicrobial peptides against common and emerging CF pathogens.
- To compare the susceptibility of Pseudomonas aeruginosa, Achromobacter xylosoxidans, and Stenotrophomonas maltophilia to AMPs.
- To investigate the role of bacterial cell surface charge in AMP resistance.
Main Methods:
- Utilized clinical isolates of P. aeruginosa, A. xylosoxidans, and S. maltophilia from CF patients.
- Evaluated antimicrobial activity using radial diffusion assays and viable bacterial counts.
- Assessed bacterial cell surface zeta potential to determine net surface charge.
Main Results:
- Achromobacter xylosoxidans exhibited the highest resistance to tested antimicrobial peptides.
- Pseudomonas aeruginosa demonstrated the greatest susceptibility to antimicrobial peptides.
- A significantly more negative surface zeta potential was observed in P. aeruginosa compared to A. xylosoxidans.
Conclusions:
- Bacterial surface charge significantly influences susceptibility to antimicrobial peptides.
- A. xylosoxidans represents a more challenging target for antimicrobial peptides than P. aeruginosa in CF infections.
- These findings highlight the need for tailored therapeutic strategies against specific CF pathogens.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Gene Regulation in Microbial Communities: Quorum Sensing

